February 15, 2017 — GE Healthcare announced U.S. Food and Drug Administration (FDA) 510(k) clearance of GSI Xtream on Revolution CT (computed tomography). The company also announced the first series of clinical images and first installations at Duke University Medical Center (USA), Robarts Research Institute (Canada) and The First Affiliated Hospital of Dalian Medical University (China).

February 15, 2017 — Deep learning, also known as artificial intelligence, will increasingly be used in the interpretation of medical images to address many long-standing industry challenges. This will lead to a $300 million market by 2021, according to a new report by Signify Research, an independent supplier of market intelligence and consultancy to the global healthcare information technology industry.

Mercator MedSystems announced that the national co-principal investigators of the company’s DANCE trial each presented comprehensive 13-month trial data during Late-Breaking sessions at ISET (International Symposium on Endovascular Therapy) in Hollywood, Fla., and LINC (Leipzig Interventional Course) in Leipzig, Germany.

Better hospital supply chain management leads to better quality of care and supports patient safety, according to a new Cardinal Health survey of hospital staff and decision makers. Despite respondents rating their supply chain processes as “good,” one in four hospital staff have seen or heard of expired product being used on a patient, and 18 percent have seen or heard of a patient being harmed due to a lack of necessary supplies.

Doctors at the University of Alabama at Birmingham have implemented the first U.S. Food and Drug Administration (FDA)-approved patent foramen ovale occluder in Alabama.

The PRO-Kinetic Energy Cobalt Chromium (CoCr) Coronary Stent System from Biotronik has gained U.S. Food and Drug Administration (FDA) approval utilizing results from the BIOHELIX-I clinical study. This stent, which has already been used to treat more than 650,000 patients worldwide, is now available in the United States.

heart team, hybird OR, structural heart team

In the current era of healthcare reform and the push toward evidence-based medicine to both lower costs and improve patient outcomes, the heart team approach to cardiac care has gained momentum. This is especially true in the area of structural heart intervention, where the concept was pioneered during the CoreValve and Sapien transcatheter aortic valve replacement (TAVR) trials.

Biotronik has developed an online tool that streamlines the workflow for physicians selecting the right magnetic resonance (MR)-conditional heart monitor or pacing or implantable cardioverter defibrillator (ICD) system for their patients.

The National Institute for Health and Care Excellence (NICE) in the United Kingdom recently issued guidance for use of the HeartFlow FFRct (fractional flow reserve computed tomography) Analysis to help determine the cause of stable chest pain in patients. Developed by HeartFlow Inc., the HeartFlow FFRct Analysis is the first non-invasive technology to provide insight into both the extent of coronary artery disease and the impact that disease has on blood flow to the heart, enabling clinicians to select an appropriate treatment.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now